Article Highlights
Updates every hour. Last Updated: 24-Oct-2026 16:15 ET (24-Oct-2026 20:15 GMT/UTC)
Insights into advantages and limitations of network pharmacology in traditional Chinese medicine
Xia & He Publishing Inc.- Journal
- Future Integrative Medicine
HKU marine scientists reveal giant clam feeding strategy could determine their future survival
The University of Hong Kong- Journal
- Communications Biology
Thymus function may hold the key to understanding immune ageing
Science Exploration PressResearchers from the Southern University of Science and Technology propose a “thymus-centric” framework to combat immunosenescence and improve health outcomes in older adults.
- Journal
- Ageing and Cancer Research & Treatment
- Funder
- Guangdong Science and Technology Program, Shenzhen Science and Technology Program, Shenzhen Science and Technology Program
Powering forward: A year of discovery in mitochondrial science
KeAi Communications Co., Ltd.- Journal
- Mitochondrial Communications
Editors’ picks high-impact articles
Higher Education Press- Journal
- UroPrecision
toGC: a new tool for correcting errors in gene annotations using RNA-seq data
KeAi Communications Co., Ltd.Researchers in China developed toGC, a new tool that corrects errors in gene annotations using RNA-seq data. Experimentally validated toGC's accuracy, discovering two novel GPCR genes misannotated as one. Demonstrated toGC's broad utility by applying it successfully to multiple oomycete species.
- Journal
- Journal of Integrative Agriculture
- Funder
- National Natural Science Foundation of China, “Innovative and Entrepreneurial Talent” Program, China, Yuanchao Wang from the Chinese Modern Agricultural Industry Technology System
Mizzou researchers are developing a rewritable DNA hard drive
University of Missouri-ColumbiaScientists are exploring synthetic DNA as a way to store massive amounts of data. Now, University of Missouri researchers, led by Li-Qun “Andrew” Gu, are taking it a step further by developing a method to make DNA storage reusable.
- Journal
- PNAS Nexus
HPV genotype as a predictor of bevacizumab treatment response in recurrent respiratory papillomatosis patients
Higher Education PressA landmark clinical study identifies Human Papillomavirus (HPV) genotype as a significant independent predictor of treatment response in patients with Recurrent Respiratory Papillomatosis (RRP), revealing that tumors associated with HPV-11 exhibit a substantially better response to intralesional bevacizumab therapy compared to those driven by HPV-6.